Lifearc

Jonathan Large

Simon Osborne

A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, &#x2022; B is a saturated or partially unsaturated monocyclic or bicyclic, heterocyclic group optionally substituted by one or more R 10 groups; *X is selected from SO, CO, CO, CONRand (CRR) p. Said compounds are capable of inhibiting PAICS and are useful in the treatment of proliferative disorders. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I). 

Oxazole derivatives for use in the treatment of cancer

A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein: &#x2022;B is an aryl or heteroaryl group optionally substituted by one or more Rgroups; and *X is selected from 0, (CRR)p and (CRR)p CO. Said compounds are capable of inhibiting PAICS and are useful in the treatment of proliferative disorders. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I). 

Growing community of inventors

London, United Kingdom

Jonathan Large